D-0755-2026 Class II Ongoing
FDA drug recall D-0755-2026 was initiated by Apollo Care, LLC on July 29, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material The recall status is ongoing. Affected quantity: 250 vials..
Recall Details
- Product Type
- Drugs
- Report Date
- August 19, 2026
- Initiation Date
- July 29, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 250 vials.
Product Description
SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01
Reason for Recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Distribution Pattern
Nationwide within the U.S
Code Information
Lot: AC-017273, Exp. 12/12/2026.